| The geriatric nutritional risk index (GNRI) as a prognostic biomarker for immune checkpoint inhibitor response in recurrent and/or metastatic head and neck cancer M Haas, A Lein, T Fuereder, FF Brkic, J Schnoell, DT Liu, ... Nutrients 15 (4), 880, 2023 | 10 | 2023 |
| Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab M Haas, A Lein, T Fuereder, J Schnoell, FF Brkic, DT Liu, ... Investigational New Drugs 41 (5), 727-736, 2023 | 3 | 2023 |
| Impact of the COVID-19 pandemic on management of surgically treated laryngeal squamous cell carcinoma A Lein, DT Liu, M Haas, A Salkic, A Ibrisevic, S Uscuplic, A Harcinovic, ... Biomolecules and Biomedicine 24 (1), 188, 2024 | 2 | 2024 |
| In vitro antineoplastic effects of MK0752 in HPV-positive head and neck squamous cell carcinoma S Varatanovic, S Stoiber, M Haas, A Lein, L Kadletz-Wanke, FF Brkic Journal of Cancer Research and Clinical Oncology 149 (16), 14691-14699, 2023 | 1 | 2023 |
| Immunohistochemical assessment of microvessel density in OSCC: spatial heterogeneity of angiogenesis and its impact on survival A Mamilos, A Lein, L Winter, M Haas, TE Reichert, T Ettl, J Künzel, ... Biomedicines 11 (10), 2724, 2023 | 1 | 2023 |
| Meteorological extremes and their impact on tinnitus-related emergency room visits: a time-series analysis M Haas, M Lucic, F Pichler, A Lein, FF Brkic, D Riss, DT Liu European Archives of Oto-Rhino-Laryngology 280 (9), 3997-4007, 2023 | 1 | 2023 |
| Targeting TGF beta receptor 1 in head and neck squamous cell carcinoma BJ Jank, J Schnoell, K Kladnik, C Sparr, M Haas, E Gurnhofer, AL Lein, ... Oral Diseases, 2023 | 1 | 2023 |
| Tumor Immune Microenvironment Heterogeneity at the Invasion Front and Tumor Center in Oral Squamous Cell Carcinoma as a Perspective of Managing This Cancer Entity A Mamilos, A Lein, L Winter, T Ettl, J Künzel, TE Reichert, G Spanier, ... Journal of Clinical Medicine 12 (4), 1704, 2023 | 1 | 2023 |
| Adverse events of the new generation of active bone conduction hearing implants (BCI602 and OSI200): a MAUDE database analysis FF Brkic, A Lein, WD Baumgartner Laryngo-Rhino-Otologie 103 (S 02), 2024 | | 2024 |
| Current insights from the latest Bone-Conduction hearing Implant (BCI 602)–A systematic review and meta-analysis A Lein, WD Baumgartner, D Riss, W Gstöttner, LD Landegger, DT Liu, ... Laryngo-Rhino-Otologie 103 (S 02), 2024 | | 2024 |
| Changes in management of head and neck malignancies during the COVID-19 pandemic A Lein, F Brkic, DT Liu, M Haas, A Salkic, A Ibrisevic, S Uscuplic, ... ACTA Otorhinolaryngologica Italica, 1-7, 2024 | | 2024 |
| Early Results With the New Active Bone‐Conduction Hearing Implant: A Systematic Review and Meta‐Analysis A Lein, WD Baumgartner, D Riss, W Gstöttner, LD Landegger, DT Liu, ... Otolaryngology–Head and Neck Surgery, 2024 | | 2024 |
| Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with … M Haas, A Lein, T Fuereder, J Schnoell, FF Brkic, NJ Campion, DT Liu, ... International Immunopharmacology 123, 110799, 2023 | | 2023 |
| Malnutrition and immunotherapy: Nutritional risk index (NRI) and Geriatric nutritional risk index (GNRI) predict survival and therapy response in head and neck cancer patients A Lein, M Haas, G Heiduscka, B Jank Laryngo-Rhino-Otologie 102 (S 02), 2023 | | 2023 |
